Arch Gynecol Obstet. 2022 May 14. doi: 10.1007/s00404-022-06587-0. Online ahead of print.
ABSTRACT
PURPOSE: To analyze endometrial metabolite profiles between patients with endometrial cancer and controls.
METHODS: Seventeen (17) women with endometrium cancer and 18 controls were enrolled in this study. 1H HR-MAS (High Resolution-Magic Angle Spinning) NMR (Nuclear Magnetic Resonance) spectroscopy data obtained from endometrial tissue samples of patients with endometrial cancer and control group were analyzed with bioinformatics methods.
RESULTS: Principal component analysis (PCA) and the partial least squares discriminant analysis (PLS-DA) score plots obtained with the multivariate statistical analysis of pre-processed spectral data shows a separation between the samples from patients with endometrial cancer and controls. Analysis results suggest that the levels of lactate, glucose, o-phosphoethanolamine, choline, glycerophosphocholine, phosphocholine, leucine, isoleucine, valine, glutamate, glutamine, n-acetyltyrosine, methionine, taurine, alanine, aspartate and phenylalanine are increased in patients with endometrial cancer compared to the controls.
CONCLUSION: The metabolomics signature of patients with endometrial cancer is different from that of benign endometrial tissue.
PMID:35567635 | DOI:10.1007/s00404-022-06587-0
